Welcome
Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.
Ad-hoc News
Key performance indicatorsVitruvia Medical AG share
| Name | Werte |
|---|---|
| WKN | A2PDWF |
| ISIN | CH0461931419 |
| Valor | CH046193141 |
| Number of shares | The share capital is CHF 1,827,757.00 and is divided into 1,827,757 registered shares, each with a nominal value of CHF 1.00. |
| Availability of shares | All registered shares are freely transferable. |
| End of fiscal year | December 31 |
| Stock exchange | Munich Stock Exchange |
| Market segment | General open market |
| Initial listing | May 11, 2021 |
Course data
| Name | Werte |
|---|---|
| Current share price (Link to Munich Stock Exchange) | |
| 52-Week-High | EUR 22,60 |
| 52-Week-Low | EUR 11,00 |
Dates
Sep 27, 2021 | Extraordinary General Assembly
Vitruvia Medical AG
Sep 19, 2021 | Publication of half-year financial statements as of June 30, 2021 Vitruvia Medical AG (Group)
Sep 19, 2021 | Publication of half-year report as of
June 30, 2021 Vitruvia Medical AG (Group)
Mar 31, 2021 | Annual General Assembly
Feb 28, 2021 | Publication of annual financial statements
Financial reports
Management Transactions
Your contact
Markus A. Bertschin
President of the Board of Directors
T +41 (0)44 915 33 78
M +41 (0)79 233 26 09
bertschin@vitruvia-med.com
Vitruvia Medical AG
Kesselackerstrasse 18
5611 Anglikon I Switzerland
Torsten Cejka
Board of Directors
T +41 (0)44 915 33 78
M +49 (0) 173 887 18 11
cejka@vitruvia-med.com
Vitruvia Medical AG
Margaretenstr. 14
39218 Schönebeck (Elbe) I Germany